iShares Trust - iShares Nasdaq Biotechnology ETF

IBB

US4642875565

Investment Trusts

Real-time Estimate Cboe BZX Other stock markets 11:01:29 2024-04-18 am EDT			5-day change	1st Jan Change
125.9 ^USD	-24.87%		-1.60%	+10.59%

2023	IShares Trust - iShares Biotechnology ETF Reports Earnings Results for the Half Year Ended September 30, 2023	CI
2023	IShares Trust - iShares Biotechnology ETF Reports Earnings Results for the Full Year Ended March 31, 2023	CI

Ishares Trust - Ishares Nasdaq Biotechnology Etf Reports Earnings Results for the Half Year Ended September 30, 2019

December 05, 2019 at 08:17 am EST

iShares Trust - iShares Nasdaq Biotechnology ETF announced earnings results for the half year ended September 30, 2019. For the half year, the company announced total revenue was USD 26.935 million. Net loss was USD 839.685 million.

Latest news about iShares Trust - iShares Nasdaq Biotechnology ETF

IShares Trust - iShares Biotechnology ETF Reports Earnings Results for the Half Year Ended September 30, 2023	Dec. 01	CI
IShares Trust - iShares Biotechnology ETF Reports Earnings Results for the Full Year Ended March 31, 2023	23-06-01	CI
IShares Trust - iShares Nasdaq Biotechnology ETF Reports Earnings Results for the Full Year Ended March 31, 2021	21-06-04	CI
Ishares Trust - Ishares Nasdaq Biotechnology Etf Reports Earnings Results for the Full Year Ended March 31, 2020	20-06-04	CI
Ishares Trust - Ishares Nasdaq Biotechnology Etf Reports Earnings Results for the Half Year Ended September 30, 2019	19-12-05	CI
IShares Trust - iShares Nasdaq Biotechnology ETF Announces Audited Earnings Results for the Full Year Ended March 31, 2019	19-06-07	CI

Chart iShares Trust - iShares Nasdaq Biotechnology ETF

Duration

Period

Chart iShares Trust - iShares Nasdaq Biotechnology ETF

More charts

Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund's investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.

Sector

Investment Trusts

More about the company

Sector Investment Trusts

	1st Jan change	Capi.
SCOTTISH MORTGAGE INVESTMENT TRUST PLC	+1.69%	14.2B
F&C INVESTMENT TRUST PLC	+0.94%	6.09B
POLAR CAPITAL TECHNOLOGY TRUST PLC	+11.08%	4.39B
ALLIANCE TRUST PLC	+8.45%	4.24B
GREENCOAT UK WIND PLC	-10.20%	3.93B
RIT CAPITAL PARTNERS PLC	-3.24%	3.22B
JPMORGAN GLOBAL GROWTH & INCOME PLC	+8.73%	3.19B
THE MONKS INVESTMENT TRUST PLC	+5.37%	3.01B
HGCAPITAL TRUST PLC	+9.66%	2.74B

Investment Trusts